STERIS’ (TSE:STE – Free Report) – Investment analysts at Atb Cap Markets reduced their Q3 2024 earnings per share estimates for STERIS’ in a report released on Tuesday, October 1st. Atb Cap Markets analyst W. Syed now anticipates that the company will earn $0.19 per share for the quarter, down from their prior estimate of $0.29. Atb Cap Markets also issued estimates for STERIS’’s FY2024 earnings at $0.77 EPS, Q1 2025 earnings at $0.45 EPS, Q3 2025 earnings at $0.31 EPS and Q1 2026 earnings at $0.40 EPS.
STERIS’ (TSE:STE – Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported C$0.14 EPS for the quarter, topping analysts’ consensus estimates of C$0.12 by C$0.02. The firm had revenue of C$231.38 million for the quarter, compared to the consensus estimate of C$226.20 million.
STERIS’ Price Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Articles
- Five stocks we like better than STERIS’
- 3 Healthcare Dividend Stocks to Buy
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- NYSE Stocks Give Investors a Variety of Quality Options
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
